Manufacturing and Scientific Affairs

Mylan has a vast manufacturing platform in India which comprises nine 8 pharmaceutical ingredient (API), 6 oral solid dose (OSD) and 5 injectables manufacturing units that serve a number of markets around the world and produce medicines in a wide range of therapeutic areas.

Market around the world Mylan

Seventeen  of Mylan’s facilities in India, including nine of its API facilities, are approved by the U.S. Food and Drug Administration (FDA). Many of the sites also are approved and regularly inspected by other regulatory authorities, including Australia's Therapeutic Goods Administration, the U.K.’s Medicines and Healthcare Products Regulatory Agency and the World Health Organization.

R&D Network

Mylan’s globally integrated R&D platform is expanding our product portfolio to satisfy unmet medical needs. We have < 3000 scientific affairs workforce  who work collaboratively across multiple R&D centers around the world. About half of our scientific affairs workforce is based in India.

Mylan R & D Centres


Find a Mylan India facility

Scientific Affairs

At Mylan, we are unconventional, visionary and bold. We see possibilities and bring them to life.


We have made Quality a habit. That’s why people across the world count on Mylan.
  • Questions?

    Get more information on our products, services and Mylan Global Center locations.
    Contact Us
  • Business Opportunities

    Do you have an opportunity or a collaboration idea?
    Partner with us